Rosenblum Silverman Sutton’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-67,426
Closed -$6.19M 73
2021
Q4
$6.19M Sell
67,426
-123
-0.2% -$14.7K 1.39% 26
2021
Q3
$8.57M Sell
67,549
-51
-0.1% -$7.42K 1.96% 19
2021
Q2
$11.2M Buy
67,600
+629
+0.9% +$102K 2.53% 14
2021
Q1
$12.2M Sell
66,971
-546
-0.8% -$127K 3.12% 12
2020
Q4
$13.5M Sell
67,517
-326
-0.5% -$66.3K 3.52% 9
2020
Q3
$14.9M Sell
67,843
-892
-1% -$189K 4.17% 6
2020
Q2
$13.1M Sell
68,735
-6,071
-8% -$1.06M 4.21% 6
2020
Q1
$11.6M Sell
74,806
-3,821
-5% -$445K 4.63% 4
2019
Q4
$6.58M Sell
78,627
-921
-1% -$70.1K 2.4% 18
2019
Q3
$5.39M Sell
79,548
-25
-0% -$1.65K 2.08% 23
2019
Q2
$5.28M Sell
79,573
-2,880
-3% -$168K 2.01% 23
2019
Q1
$4.58M Buy
82,453
+57,444
+230% +$3.51M 1.82% 25
2018
Q4
$1.12M Sell
25,009
-62,436
-71% -$3.82M 0.51% 42
2018
Q3
$7.55M Sell
87,445
-1,522
-2% -$108K 2.5% 12
2018
Q2
$5.17M Buy
88,967
+25,642
+40% +$1.25M 1.79% 21
2018
Q1
$2.55M Sell
63,325
-4,610
-7% -$174K 0.91% 38
2017
Q4
$2.37M Sell
67,935
-170
-0.2% -$5.64K 0.85% 37
2017
Q3
$2.26M Buy
68,105
+710
+1% +$23.3K 0.86% 39
2017
Q2
$2.34M Buy
67,395
+1,800
+3% +$52.5K 0.93% 38
2017
Q1
$1.64M Sell
65,595
-12,730
-16% -$265K 0.69% 45
2016
Q4
$1.29M Sell
78,325
-5,975
-7% -$101K 0.61% 46
2016
Q3
$1.54M Buy
84,300
+7,450
+10% +$131K 0.71% 43
2016
Q2
$1.23M Buy
+76,850
New +$897K 0.59% 45

Other funds holding TDOC

Rosenblum Silverman Sutton's TDOC Position: Q1 2022 in Review

Rosenblum Silverman Sutton sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 67,426 shares — an estimated $6.19M sold.

Rosenblum Silverman Sutton first reported a position in TDOC in Q2 2016 and held it in 23 quarters. The position peaked at $14.9M in Q3 2020. 679 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Rosenblum Silverman Sutton reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Rosenblum Silverman Sutton sold 67,426 Teladoc Health shares in Q1 2022, an estimated $6.19M.
  • Rosenblum Silverman Sutton first reported a position in Teladoc Health in Q2 2016 and held it in 23 quarters.
  • Rosenblum Silverman Sutton's Teladoc Health position peaked at $14.9M in Q3 2020.
  • 679 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Rosenblum Silverman Sutton's 13F filing for Q1 2022, filed 13 May 2022.